CoChat

MiR‐Score: A novel 6‐microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma

Open access
Kirschner, Michaela B., Cheng, Yuen Yee, Armstrong, Nicola J., Lin, Ruby C.Y., Kao, Steven C., Linton, Anthony, Klebe, Sonja, McCaughan, Brian C., van Zandwijk, Nico, Reid, Glen · 2015 · Molecular Oncology
Cited by 77

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background: Prognosis of malignant pleural mesothelioma (MPM) is poor, and predicting the outcomes of treatment is difficult. Here we investigate the potential of microRNA expression to estimate prognosis of MPM patients. Methods: Candidate microRNAs from microarray profiling of tumor samples from 8 long (median: 53.7 months) and 8 short (median: 6.4 months) survivors following extrapleural pneumonectomy (EPP) were validated by RT‐qPCR in 48 additional EPP samples. Kaplan–Meier log ranking was used to further explore the association between microRNA expression and overall survival (OS). Binary logistic regression was used to construct a microRNA signature (miR‐Score) that was able to predict an OS of ≥20 months. Performance of the miR‐Score was evaluated by receiver operating characteristic (ROC) curve analysis and validated in a series of 43 tumor samples from patients who underwent palliative surgery [pleurectomy/decortication (P/D)]. Results: The miR‐Score, using expression data of six microRNAs (miR‐21‐5p, ‐23a‐3p, ‐30e‐5p, ‐221‐3p, ‐222‐3p, and ‐31‐5p), enabled prediction of long survival with an accuracy of 92.3% for EPP and 71.9% for palliative P/D. Hazard ratios for score‐negative patients were 4.12 (95% CI: 2.03–8.37) for EPP and 1.93 (95% CI: 1.01–3.69) for P/D. Importantly, adding the miR‐Score to a set of clinical selection criteria (histology, age, gender) increased predictive accuracy in the independent validation set from 76.3% for clinical factors only to 87.3%. Conclusions: This study has identified a novel 6‐microRNA signature (miR‐Score) that can accurately predict prognosis of MPM patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molonc.2014.11.007

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 77

Metadata

Authors
Kirschner, M. B., Cheng, Y. Y., Armstrong, N. J., Lin, R. C. Y., Kao, S. C., Linton, A., Klebe, S., McCaughan, B. C., van Zandwijk, N., & Reid, G.
Venue
Molecular Oncology
Publisher
Wiley
Published
2014-12-02
Volume
9
Issue
3
Pages
715-726
ISSN
  • 1574-7891 (ISSN-L)
  • 1878-0261
OpenAlex
W2032004745
Cited by
77
References
2
FWCI
8.00
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MiR‐Score: A novel 6‐microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma. https://app.cochat.ai/papers/10.1016/j.molonc.2014.11.007
The paper
Kirschner, M. B., Cheng, Y. Y., Armstrong, N. J., Lin, R. C. Y., Kao, S. C., Linton, A., Klebe, S., McCaughan, B. C., van Zandwijk, N., & Reid, G. (2015). MiR‐Score: A novel 6‐microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma. Molecular Oncology. https://doi.org/10.1016/j.molonc.2014.11.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.